Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

NCT01010217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Blood Stem Cell Transplant Failure
Leukemia
Hematologic Malignancies

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Mesna
DRUG: Rituximab
PROCEDURE: Stem Cell Transplantation
DRUG: Thiotepa
DRUG: Tacrolimus
DRUG: Mycofenolate mofetil
DRUG: G-CSF

Sponsor

M.D. Anderson Cancer Center